Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Harvard Business School
Cantor Fitzgerald
Deloitte
Teva
Citi
Medtronic
Express Scripts
Cipla

Generated: May 21, 2018

DrugPatentWatch Database Preview

Cefotaxime sodium - Generic Drug Details

or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for cefotaxime sodium and what is the scope of cefotaxime sodium freedom to operate?

Cefotaxime sodium
is the generic ingredient in seven branded drugs marketed by Fresenius Kabi Usa, Hikma, Wockhardt, B Braun, Aurobindo Pharma, Aurobindo Pharma Ltd, Cephazone Pharma, Hospira Inc, Lupin, Sanofi Aventis Us, and Us Pharm Holdings, and is included in seventeen NDAs. Additional information is available in the individual branded drug profile pages.

There are fourteen drug master file entries for cefotaxime sodium. Four suppliers are listed for this compound.
Pharmacology for cefotaxime sodium
Medical Subject Heading (MeSH) Categories for cefotaxime sodium
Synonyms for cefotaxime sodium
(+)-Cefotaxime sodium salt
(6R-(6-a,7-b(Z)))-3-((Acetyloxy) methyl)-7- (((2-amino-4-thiazolyl) (methoxyimio) acetyl) amino)-8- oxo-5-thia-1- azabicyclo (4,2,0) oct-2-ene-2-carboxylic acid, sodium salt
(6R-(6-a,7-b(Z)))-3-((Acetyloxy) methyl)-7-(((2-amino-4-thiazolyl) (methoxyimio) acetyl) amino)-8-oxo-5-thia-1-azabicyclo (4,2,0) oct-2-ene-2-carboxylic acid, sodium salt
(6R,7R,Z)-3-(ACETOXYMETHYL)-7-(2-(2-AMINOTHIAZOL-4-YL)-2-(METHOXYIMINO)-ACETAMIDO)-8-OXO-5-THIA-1-AZABICYCLO[4.2.0]OCT-2-ENE-2-CARBOXYLIC ACID SODIUM
(6R,7R)-3-[(Acetyloxy)methyl]-7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid Sodium Salt
258J72S7TZ
3-[(Acetyloxy)methyl]-7-[[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amin]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate sodium salt
478250-23-6
5-Thia-1-azabicyclo(4,2,0)oct-2-ene-2-carboxylic acid, 3-((acetyloxy)methyl)-7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-8-oxo-, (6R-(6-alpha,7-beta(Z))), sodium salt
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-((acetyloxy)methyl)-7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-8-oxo-, monosodium salt, (6R-(6alpha,7beta(Z)))-
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-(acetyloxy)methyl-7-[[(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-8-oxo, monosodium salt, [6R-[6alpha,7 beta (Z)]]-
63527-52-6 (acid)
63527-52-6 (Parent)
64485-93-4
7-[2-(2-AMINO-4-THIAZOLYL)GLYOXYLAMIDO]-3-(HYDROXYMETHYL)-8-OXO-5-THIA-1-AZABICYCLO[4.2.0]OCT-2-ENE-2-CARBOXYLATE 7(2)-(Z)-(O-METHYLOXIME) ACETATE, NA
A834407
AB0073048
AB03027
AB1009356
AC-23966
AK249539
AK326216
AKOS003274997
AKOS015951272
AKOS015961149
AKOS027282526
AKOS027327590
AmbscH-042283
AN-38760
AZZMGZXNTDTSME-JUZDKLSSSA-M
BIC0111
C 7912
C08113
C16H16N5NaO7S2
C16H16N5O7S2.Na
CAS-64485-93-4
CCG-220139
CCG-221582
CCG-38937
Cefadroxil, Antibiotic for Culture Media Use Only
CEFOPERAZONE SODIUM SALT U.S.P.
Cefotax
Cefotaxim sodium
Cefotaxim sodium salt
Cefotaxime (sodium salt)
Cefotaxime and dextrose 2.4% in plastic container
Cefotaxime and dextrose 3.9% in plastic container
Cefotaxime for peak identification, European Pharmacopoeia (EP) Reference Standard
CEFOTAXIME NA-SALT
Cefotaxime sodium (JP17/USP)
Cefotaxime sodium [USAN:JAN]
Cefotaxime sodium [USAN:USP:JAN]
CEFOTAXIME SODIUM SALT
Cefotaxime sodium salt (syn-isomer)
Cefotaxime sodium salt, plant cell culture tested, BioReagent, powder
Cefotaxime sodium salt, potency: 916-964 mug per mg
Cefotaxime sodium, European Pharmacopoeia (EP) Reference Standard
Cefotaxime sodium, United States Pharmacopeia (USP) Reference Standard
Cefotaximesodium
CHEBI:3498
CHEMBL1010
CHEMBL3561962
Claforan
Claforan (TN)
CLAFORAN IN DEXTROSE 5% IN PLASTIC CONTAINER
CLAFORAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Claforan sodium
CPD001551784
D00919
DR002957
DSSTox_CID_26991
DSSTox_GSID_46991
DSSTox_RID_82039
DTXSID4046991
EINECS 264-915-9
EN300-122614
EU-0100278
FT-0603036
HE372323
HMS1568K20
HMS1920K09
HMS2091A12
HMS2095K20
HMS2233J21
HMS3259D08
HMS3260H18
HMS3373G07
HMS502G09
HR 756
HR-756
I06-1759
J10142
K035
KS-00004E9I
KS-1416
LP00278
LS-149921
MCULE-9988072641
MFCD00079073
MFCD19705570
MLS000028559
MLS001077352
MLS001333684
MLS002222330
MolPort-003-928-040
MolPort-016-582-515
MolPort-027-714-060
NC00704
NCGC00017128-01
NCGC00093734-01
NCGC00093734-02
NCGC00260963-01
NE54506
Opera_ID_1945
Prestwick_823
Pretor
Q-200807
Ralopar
RU 24756
s4517
SAM002643511
SCHEMBL41092
SCHEMBL537163
SCHEMBL9491367
SMR000058812
SMR000653480
SMR001307269
Sodium (6R-(6alpha,7beta(Z)))-3-(acetoxymethyl)-7-((2-aminothiazol-4-yl)(methoxyimino)acetamido)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate
SODIUM (6R,7R)-3-(ACETOXYMETHYL)-7-((E)-2-(2-AMINOTHIAZOL-4-YL)-2-(METHOXYIMINO)ACETAMIDO)-8-OXO-5-THIA-1-AZABICYCLO[4.2.0]OCT-2-ENE-2-CARBOXYLATE
Sodium (6R,7R)-3-(acetoxymethyl)-7-((Z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
sodium (6R,7R)-3-(acetoxymethyl)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-methoxyimino-acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
sodium (6R,7R)-3-(acetoxymethyl)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
sodium (6R,7R)-3-[(acetyloxy)methyl]-7-[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
sodium (6R,7R)-3-[(acetyloxy)methyl]-7-[2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
Sodium (6R,7R)-7-(2-(2-amino-4-thiazolyl)glyoxylamido)-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate 7(sup 2)-(Z)-(O-methyloxime), acetate (ester)
Sodium (6R,7R)-7-[2-(2-amino-4-thiazolyl)glyoxylamido]-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate 7[2]-(Z)-(O-methyloxime), acetate (ester)
SODIUM (6S,7S)-3-[(ACETYLOXY)METHYL]-7-[(2Z)-2-(2-AMINO-1,3-THIAZOL-4-YL)-2-(METHOXYIMINO)ACETAMIDO]-8-OXO-5-THIA-1-AZABICYCLO[4.2.0]OCT-2-ENE-2-CARBOXYLATE
Sodium 3-(acetoxymethyl)-7-(2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
sodium 3-(acetoxymethyl)-7beta-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3,4-didehydrocepham-4-carboxylate
sodium 3-(acetyloxymethyl)-7-[[2-(2-amino-4-thiazolyl)-2-methoxyimino-1-oxoethyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
sodium 3-(acetyloxymethyl)-7-[[2-(2-azanyl-1,3-thiazol-4-yl)-2-methoxyimino-ethanoyl]amino]-8-oxidanylidene-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
sodium 3-[(acetyloxy)methyl]-7-[2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
sodium 3-[(acetyloxy)methyl]-7-{[(2-amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-
Sodium 7-(2-(2-amino-4-thiazolyl)-2-methoxyiminoacetamido)cephalosporanate
Sodium cefotaxime
sodium;(6R,7R)-3-(acetyloxymethyl)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
SPECTRUM1500165
TL8004572
Tolycar
Tolycor
Tox21_110791
Tox21_500278
UNII-258J72S7TZ
Zariviz

US Patents and Regulatory Information for cefotaxime sodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wockhardt CEFOTAXIME SODIUM cefotaxime sodium INJECTABLE;INJECTION 065197-002 Jun 20, 2008 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Lupin CEFOTAXIME SODIUM cefotaxime sodium INJECTABLE;INJECTION 065124-003 Sep 24, 2003 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Fresenius Kabi Usa CEFOTAXIME cefotaxime sodium INJECTABLE;INJECTION 064201-001 Mar 24, 2000 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Aurobindo Pharma CEFOTAXIME SODIUM cefotaxime sodium INJECTABLE;INJECTION 065517-003 Nov 6, 2009 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Boehringer Ingelheim
Healthtrust
AstraZeneca
QuintilesIMS
Cantor Fitzgerald
Medtronic
Deloitte
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.